Skip to content

Pro-Dex, Inc. PDEX Change in Deferred Revenue

Change in Deferred Revenue at other companies

IAR
Integra LifeSciencesIART
-$630K-358%
Plexus logo
PlexusPLXS
-$14.29M+8.4%
Biodesix, Inc. logo
Biodesix, Inc.BDSX
-$766K-1,023%
Rapid Micro Biosystems logo
Rapid Micro BiosystemsRPID
$1.9M+475%

Other financials

Income statement

See full
Revenue$19.9M+14.6%
Gross profit$6.1M+5.8%
Operating income$3.1M-15.0%
Net income$3.9M+20.2%
EPS (diluted)$1.20+22.4%

Balance sheet

See full
Cash & equivalents$10.0M+123%
Total debt$16.0M+43.2%
Total equity$45.2M+28.1%
Total assets$75.0M+16.7%

Cash flow

See full
Operating cash flow$1.6M+488%
CapEx$112.0K-37.8%
Free cash flow$1.5M

Valuation

See full
Market cap$195.81M+39.3%
Enterprise value$201.8M+34.4%
P/E16.3×+0.7×
P/S2.6×+0.5×

Profitability

See full
Gross margin27.8%-3.6pp
Operating margin14.5%-3.8pp
Net margin16.1%+1.5pp
FCF margin-3.8%+3.2pp

Returns & leverage

See full
Return on equity29.8%+1.5pp
Debt / equity0.4×0.0×
Current ratio3.7×+0.9×

Where this comes from

Reported directly by Pro-Dex, Inc. in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInDeferredRevenue.

The official record: Pro-Dex, Inc.’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Pro-Dex, Inc.'s change in deferred revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Pro-Dex, Inc.'s change in deferred revenue?
Pro-Dex, Inc. (PDEX) reported change in deferred revenue of -$19K in Q1 2026.
What is the long-term trend for Pro-Dex, Inc.'s change in deferred revenue?
Over 2 years (2022 to 2024), Pro-Dex, Inc.'s change in deferred revenue has grown at a -87.3% compound annual growth rate (CAGR), from $863K to $14K.
What does change in deferred revenue mean?
Change in payments received from customers for goods/services not yet delivered — a key SaaS and subscription metric.